BioNTech
Kelly Simpliciano is the Director Audit Management, Global Quality Assurance GCP at BioNTech SE. Prior to joining BioNTech, Kelly held various roles at Bristol-Myers Squibb, including Associate Director in Global Quality - Clinical Trials & Safety, Associate Director in Information Technology Quality Assurance (ITQA), and Associate Director in R&D Quality, Information Technology Quality Assurance (ITQA). Kelly's expertise lies in auditing Investigator sites, clinical vendors, and internal audits within the Global Quality organization. With a background in environmental science from Rutgers University and a Master of Science in Quality Assurance and Regulatory Affairs from Temple University, Kelly has demonstrated strong leadership in computer system validation efforts and IT compliance audits.
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.